FDA grants priority review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults Read more
CanSinoBIO’s COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China Read more
SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor Read more
Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder Read more
Novartis announces European Commission approval of Beovu for people living with diabetic macular edema Read more
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) Read more
Receptor Life Sciences Announces FDA Acceptance of IND Application for RLS103 (Inhaled Dry Powder CBD) and Initiation of IND-Opening Clinical Safety and Efficacy Study Read more
CytoDyn Announces Partial Clinical Hold of HIV Program and Full Clinical Hold of COVID-19 Program Read more
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson’s Disease Read more